Singapore Pharmaceuticals and Healthcare Report Q1 2015

Business Monitor International
November 26, 2014
133 Pages - SKU: BMI5392084
Countries covered: Singapore

Singapore Pharmaceuticals and Healthcare Report Q1 2015

BMI View: Driven by a rapidly ageing population and growing government health expenditure,Singapore's pharmaceutical sales will continue its steady growth over the next decade. This growth is onlyconstrained by its small population. The country's high levels of education, strong patent protection andgood infrastructure also makes it a highly competitive location for international pharmaceutical companiesto establish research and development and manufacturing facilities as the region integrates closer with theASEAN Economic Community.

Headline Expenditure Projections

Pharmaceuticals: SGD990mn (USD790mn) in 2013 to SGD1.04bn (USD830mn) in 2014; +5.5% inlocal currency terms and +5.0% in US dollar terms. Forecast unchanged from Q414.

Healthcare: SGD17.78bn (USD14.21bn) in 2013 to SGD19.33bn (USD15.38bn) in 2014; +8.7% in localcurrency terms and +8.3% in US dollar terms.



More Prescription Drugs reports by Business Monitor International

Taiwan Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Taiwan Pharmaceuticals and Healthcare Report Q1 2015BMI View: Taiwan is one of the most attractive and stable prospects in the region for pharmaceutical andhealthcare investment, ...
Switzerland Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Switzerland Pharmaceuticals and Healthcare Report Q1 2015BMI View: The Swiss government will need to develop policies to maintain the country's long-termattractiveness as a site for ...
Sudan Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Sudan Pharmaceuticals and Healthcare Report Q1 2015BMI View: The already depreciating Sudanese pound will come under further strain should oil pricescontinue their decline as oil ...
Saudi Arabia Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Saudi Arabia Pharmaceuticals and Healthcare Report Q1 2015BMI View: We expect heavy investment into Saudi Arabia's healthcare sector to continue, particularly asthe government sees the ...
See all reports like this >>

More Singapore Prescription Drugs reports

Singapore Pharmaceutical Industry Report - 2014 by Emerging Markets Direct Reports
Singapore Pharmaceutical Industry Report - 2014This report profiles Singapore’s pharmaceutical industry, analyzing sector size and performance, competitive landscape, recent development in the industry as well ...
Singapore Healthcare Industry 2H12 by Emerging Markets Direct Reports
Singapore: Healthcare covers the Asia-Pacific overview, general overview of Singapore, and Singapore healthcare industry including social development and healthcare services. It also covers the market ...
Antibiotics Market in Singapore to 2016 by Global Research & Data Services
This market research report offers a perspective on the actual market situation, trends and future outlook for antibiotics in Singapore. The study provides essential market ...
The Pharmaceutical Market: Singapore by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
See all reports like this >>

 

SELECT A LICENSE

    PDF E-mail From Publisher  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!